SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-100748
Filing Date
2024-04-18
Accepted
2024-04-18 16:01:39
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d767575ds3.htm S-3 181401
2 EX-5.1 d767575dex51.htm EX-5.1 8143
3 EX-23.1 d767575dex231.htm EX-23.1 2053
4 EX-FILING FEES d767575dexfilingfees.htm EX-FILING FEES 20174
5 GRAPHIC g767575g00a01.jpg GRAPHIC 64497
6 GRAPHIC g767575g0417044338252.jpg GRAPHIC 2661
7 GRAPHIC g767575g05a05.jpg GRAPHIC 64814
  Complete submission text file 0001193125-24-100748.txt   395038
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278792 | Film No.: 24854277
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)